Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypertension, Rash, Rash pruritic, Somnolence
Clinical narrative: Blood pressure was 195/96; Shortness of breath; Confusion; Weakness; Diarrhea; Speech was slurred; Additional rashes appeared; Chills; Tired; Headache; Joint pain; rashes that started to appear, itching, discomfort; Discomfort; Slept most of the night; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERTENSION (Blood pressure was 195/96) and DYSPNOEA (Shortness of breath) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMINS NOS for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced SOMNOLENCE (Slept most of the night). On 15-Mar-2021, the patient experienced RASH PRURITIC (rashes that started to appear, itching, discomfort), DISCOMFORT (Discomfort) and ARTHRALGIA (Joint pain). On 16-Mar-2021, the patient experienced HYPERTENSION (Blood pressure was 195/96) (seriousness criterion hospitalization), DYSPNOEA (Shortness of breath) (seriousness criterion hospitalization), CONFUSIONAL STATE (Confusion), ASTHENIA (Weakness), DIARRHOEA (Diarrhea), DYSARTHRIA (Speech was slurred), RASH (Additional rashes appeared), CHILLS (Chills), FATIGUE (Tired) and HEADACHE (Headache). The patient was hospitalized from 16-Mar-2021 to 17-Mar-2021 due to DYSPNOEA and HYPERTENSION. The patient was treated with FLUTICASONE PROPIONATE (FLONAZE) (intravenous) at an unspecified dose and frequency; FAMOTIDINE at an unspecified dose and frequency and PREDNISONE at an unspecified dose and frequency. On 13-Mar-2021, SOMNOLENCE (Slept most of the night) had resolved. On 16-Mar-2021, HYPERTENSION (Blood pressure was 195/96), CONFUSIONAL STATE (Confusion) and DYSARTHRIA (Speech was slurred) had resolved. On 17-Mar-2021, RASH PRURITIC (rashes that started to appear, itching, discomfort), DIARRHOEA (Diarrhea) and RASH (Additional rashes appeared) had resolved. At the time of the report, DYSPNOEA (Shortness of breath) had not resolved and DISCOMFORT (Discomfort), ASTHENIA (Weakness), ARTHRALGIA (Joint pain), CHILLS (Chills), FATIGUE (Tired) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Blood pressure measurement: 195/96 (High) units not provided.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.